Humza Bhatti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Humza Bhatti has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Aghdas Movassaghi
2 shared publications- Austin Goodyke
Corewell Health
2 shared publications - Jeremy W. Prokop
Office of Research, Corewell Health, Grand Rapids, USA
2 shared publications - Adam C. Underwood
Division of Mathematics and Science, Walsh University, North Canton, OH 44720, USA
1 shared publication - Adam J. Caulfield
Microbiology Lab, Corewell Health, Grand Rapids, MI 49503, USA
1 shared publication Akansha S. Das
Michigan State University
1 shared publication
Latest Publications
- Open Access
- 13 June 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10 (3)
Sex-Associated Differences in Deltoid and Rotator Cuff Muscle Elongation After Reverse Shoulder Arthroplasty with the INHANCE Shoulder System
- 13 June 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10 (3)
Open AccessSex-Associated Differences in Deltoid and Rotator Cuff Muscle Elongation After Reverse Shoulder Arthroplasty with the INHANCE Shoulder System
- Open Access
- 5 March 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (2) , 100711
Impact of area deprivation index on outcomes and health care utilization following shoulder arthroplasty: a systematic review
- 5 March 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (2) , 100711
Open AccessImpact of area deprivation index on outcomes and health care utilization following shoulder arthroplasty: a systematic review
- 1 December 2025
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 13 (12)
Metabolic Functions of the Subacromial Bursa
» Historically viewed as a passive structure in shoulder pain, the subacromial bursa (SAB) is now understood to have metabolic function and to be an active participant in shoulder health by influencing cytokine production and cellular signaling pathways. » The variability in the SAB anatomically, along with its varied cell types, makes it an important consideration for shoulder health. Synoviocytes, mesenchymal stem cells, fibroblasts, and immune cells from the SAB can largely influence shoulder pathology. » The SAB influences metabolic function through the release of bioactive molecules such as interleukin-1, interleukin-6, tumor necrosis factor-ɑ, transformation growth factor, and basic fibroblast growth factor. These molecules alter shoulder health by modulating the immune/inflammatory response and promoting angiogenesis, cell proliferation, and fibrosis. » The SAB and its metabolic function are indicated in several clinical conditions, such as subacromial impingement syndrome, shoulder osteoarthritis, subacromial bursitis, and rotator cuff tears, demonstrating its importance and clinical utility. » Further understanding of the SAB and its metabolic function as opposed to its anatomical function allows for novel targets and therapeutics in shoulder pathologies that integrate the field of orthopaedics and immunology. Further studies demonstrating the role of the bioactive molecules released by the SAB and its effect on surrounding tissues are paramount for breakthroughs in shoulder health. » In this study, we present a narrative review of the current understanding of the metabolic function of the SAB.
- 1 December 2025
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 13 (12)
Metabolic Functions of the Subacromial Bursa
» Historically viewed as a passive structure in shoulder pain, the subacromial bursa (SAB) is now understood to have metabolic function and to be an active participant in shoulder health by influencing cytokine production and cellular signaling pathways. » The variability in the SAB anatomically, along with its varied cell types, makes it an important consideration for shoulder health. Synoviocytes, mesenchymal stem cells, fibroblasts, and immune cells from the SAB can largely influence shoulder pathology. » The SAB influences metabolic function through the release of bioactive molecules such as interleukin-1, interleukin-6, tumor necrosis factor-ɑ, transformation growth factor, and basic fibroblast growth factor. These molecules alter shoulder health by modulating the immune/inflammatory response and promoting angiogenesis, cell proliferation, and fibrosis. » The SAB and its metabolic function are indicated in several clinical conditions, such as subacromial impingement syndrome, shoulder osteoarthritis, subacromial bursitis, and rotator cuff tears, demonstrating its importance and clinical utility. » Further understanding of the SAB and its metabolic function as opposed to its anatomical function allows for novel targets and therapeutics in shoulder pathologies that integrate the field of orthopaedics and immunology. Further studies demonstrating the role of the bioactive molecules released by the SAB and its effect on surrounding tissues are paramount for breakthroughs in shoulder health. » In this study, we present a narrative review of the current understanding of the metabolic function of the SAB.
- 31 October 2025
- Published by Elsevier in Journal of Orthopaedics
- Vol. 72, 94-99
Impact of postoperative complications on patient-reported outcomes following surgical fixation of acetabular fractures
- 31 October 2025
- Published by Elsevier in Journal of Orthopaedics
- Vol. 72, 94-99
Impact of postoperative complications on patient-reported outcomes following surgical fixation of acetabular fractures
- 1 September 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 329 (3) , C848-C867
Methyl-CpG-binding domain as a protein interaction partner in promoter regulation and neurodevelopment through evolutionary expanded entanglement
The evolution of the methyl-binding domain (MBD) suggests a shared function in gene regulation, from plants to humans, with the conservation of non-DNA-interacting amino acids critical for protein-protein interactions. The MBD-regulated NuRD complex localizes to promoters of housekeeping genes with hypomethylated CpG islands. Expression profiles suggest a shared role for NuRD complex components in neurodevelopment, where the MBD3 and GATAD2B subcomplex of NuRD may be underexplored due to its non-DNA-binding biology.
- 1 September 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 329 (3) , C848-C867
Methyl-CpG-binding domain as a protein interaction partner in promoter regulation and neurodevelopment through evolutionary expanded entanglement
The evolution of the methyl-binding domain (MBD) suggests a shared function in gene regulation, from plants to humans, with the conservation of non-DNA-interacting amino acids critical for protein-protein interactions. The MBD-regulated NuRD complex localizes to promoters of housekeeping genes with hypomethylated CpG islands. Expression profiles suggest a shared role for NuRD complex components in neurodevelopment, where the MBD3 and GATAD2B subcomplex of NuRD may be underexplored due to its non-DNA-binding biology.
- Open Access
- 9 September 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (9) , 1863
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins
As of 2024, SARS-CoV-2 continues to propagate and drift as an endemic virus, impacting healthcare for years. The largest sequencing initiative for any species was initiated to combat the virus, tracking changes over time at a full virus base-pair resolution. The SARS-CoV-2 sequencing represents a unique opportunity to understand selective pressures and viral evolution but requires cross-disciplinary approaches from epidemiology to functional protein biology. Within this work, we integrate a two-year genotyping window with structural biology to explore the selective pressures of SARS-CoV-2 on protein insights. Although genotype and the Spike (Surface Glycoprotein) protein continue to drift, most SARS-CoV-2 proteins have had few amino acid alterations. Within Spike, the high drift rate of amino acids involved in antibody evasion also corresponds to changes within the ACE2 binding pocket that have undergone multiple changes that maintain functional binding. The genotyping suggests selective pressure for receptor specificity that could also confer changes in viral risk. Mapping of amino acid changes to the structures of the SARS-CoV-2 co-transcriptional complex (nsp7-nsp14), nsp3 (papain-like protease), and nsp5 (cysteine protease) proteins suggest they remain critical factors for drug development that will be sustainable, unlike those strategies targeting Spike.
- 9 September 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (9) , 1863
Open AccessSARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins
As of 2024, SARS-CoV-2 continues to propagate and drift as an endemic virus, impacting healthcare for years. The largest sequencing initiative for any species was initiated to combat the virus, tracking changes over time at a full virus base-pair resolution. The SARS-CoV-2 sequencing represents a unique opportunity to understand selective pressures and viral evolution but requires cross-disciplinary approaches from epidemiology to functional protein biology. Within this work, we integrate a two-year genotyping window with structural biology to explore the selective pressures of SARS-CoV-2 on protein insights. Although genotype and the Spike (Surface Glycoprotein) protein continue to drift, most SARS-CoV-2 proteins have had few amino acid alterations. Within Spike, the high drift rate of amino acids involved in antibody evasion also corresponds to changes within the ACE2 binding pocket that have undergone multiple changes that maintain functional binding. The genotyping suggests selective pressure for receptor specificity that could also confer changes in viral risk. Mapping of amino acid changes to the structures of the SARS-CoV-2 co-transcriptional complex (nsp7-nsp14), nsp3 (papain-like protease), and nsp5 (cysteine protease) proteins suggest they remain critical factors for drug development that will be sustainable, unlike those strategies targeting Spike.